Skip to main content
Premium Trial:

Request an Annual Quote

Quidel Extractionless COVID PCR Test Get FDA Emergency Use Authorization

NEW YORK – An assay from Quidel to detect SARS-CoV-2 without an upfront nucleic acid extraction step was granted Emergency Use Authorization from the US Food and Drug Administration on Monday. The firm has also received the CE mark for the assay.

The Quidel Lyra Direct SARS-CoV-2 assay uses a reformulated buffer and replaces the extraction step with a 10-minute heating step. This, the firm noted in a statement, can potentially relieve an ongoing bottleneck on sample extraction kits and can save 50 minutes of processing time.

The Lyra Direct runs on any of seven thermal cyclers, including the Applied Biosystems 7500 Standard and 7500 Fast, Bio-Rad CFX96 Touch, Qiagen Rotor-Gene Q, Roche LightCycler 480 and Cobas z480, and Thermo Fisher QuantStudio 7 Pro.

The Lyra Direct SARS-CoV-2 Assay also received the CE mark on May 8, Quidel said.

The assay is currently available for sale in the United States under EUA and can be purchased through Quidel directly or through Cardinal Health.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.